IRIS
GUIDO, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.698
NA - Nord America 1.874
SA - Sud America 1.442
EU - Europa 755
AF - Africa 180
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.954
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 2.008
US - Stati Uniti d'America 1.703
BR - Brasile 1.037
VN - Vietnam 772
CN - Cina 703
HK - Hong Kong 334
BD - Bangladesh 292
IT - Italia 249
FR - Francia 169
KR - Corea 164
AR - Argentina 151
IQ - Iraq 73
MX - Messico 65
EC - Ecuador 64
DE - Germania 63
IN - India 57
RU - Federazione Russa 56
CO - Colombia 51
ZA - Sudafrica 48
CA - Canada 46
GB - Regno Unito 45
NL - Olanda 42
ID - Indonesia 39
CL - Cile 36
PK - Pakistan 35
TR - Turchia 27
MA - Marocco 26
TN - Tunisia 25
VE - Venezuela 25
UZ - Uzbekistan 23
FI - Finlandia 22
PY - Paraguay 22
UY - Uruguay 22
EG - Egitto 19
SA - Arabia Saudita 19
UA - Ucraina 19
PE - Perù 18
DZ - Algeria 15
ES - Italia 15
MY - Malesia 15
PH - Filippine 14
BO - Bolivia 13
KZ - Kazakistan 13
NP - Nepal 12
AG - Antigua e Barbuda 11
JO - Giordania 11
KE - Kenya 11
AZ - Azerbaigian 10
ET - Etiopia 10
PL - Polonia 10
JP - Giappone 9
SE - Svezia 9
JM - Giamaica 8
PA - Panama 8
BH - Bahrain 7
DO - Repubblica Dominicana 7
AL - Albania 6
AT - Austria 6
CR - Costa Rica 6
KW - Kuwait 6
LB - Libano 6
AE - Emirati Arabi Uniti 5
IR - Iran 5
KG - Kirghizistan 5
OM - Oman 5
QA - Qatar 5
SN - Senegal 5
BG - Bulgaria 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
CY - Cipro 4
GT - Guatemala 4
HN - Honduras 4
IL - Israele 4
LT - Lituania 4
PS - Palestinian Territory 4
RS - Serbia 4
AU - Australia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
LK - Sri Lanka 3
LY - Libia 3
MD - Moldavia 3
NI - Nicaragua 3
SV - El Salvador 3
AO - Angola 2
BW - Botswana 2
EE - Estonia 2
GA - Gabon 2
GR - Grecia 2
HU - Ungheria 2
IE - Irlanda 2
KH - Cambogia 2
LV - Lettonia 2
PR - Porto Rico 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TG - Togo 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
Totale 8.931
Salva come PNG Salva come JPEG
Città #
Singapore 743
San Jose 491
Hong Kong 330
Ho Chi Minh City 293
Ashburn 276
Hefei 272
Council Bluffs 212
Beijing 178
Seoul 159
Hanoi 156
Lauterbourg 154
Dallas 132
São Paulo 87
New York 70
Santa Clara 49
Da Nang 41
Los Angeles 40
Amsterdam 37
Rio de Janeiro 35
Munich 28
Haiphong 27
Mexico City 26
Baghdad 25
Tianjin 24
Biên Hòa 23
Brasília 22
Phoenix 22
Rende 22
Dhaka 21
Hải Dương 20
Rome 20
Tashkent 20
Johannesburg 18
Fortaleza 17
Guayaquil 17
Quito 17
Brooklyn 16
Curitiba 16
Helsinki 16
Montevideo 16
Naples 16
Belo Horizonte 15
Campinas 15
Porto Alegre 15
Milan 14
San Francisco 14
Cape Town 13
Columbus 13
Chicago 12
Medellín 12
Toronto 12
Bogotá 11
Frankfurt am Main 11
Orem 11
Santiago 11
St John's 11
Amman 10
Istanbul 10
Lima 10
Seattle 10
Tunis 10
Addis Ababa 9
Baku 9
Boston 9
Buenos Aires 9
Buffalo 9
Can Tho 9
Guangzhou 9
Joinville 9
Nairobi 9
Nova Iguaçu 9
Salvador 9
Stockholm 9
Bologna 8
Cairo 8
Carapicuíba 8
Guarulhos 8
Jeddah 8
Karachi 8
London 8
Lấp Vò 8
Montreal 8
Osasco 8
Phủ Lý 8
Shanghai 8
Tokyo 8
Warsaw 8
Asunción 7
Casablanca 7
Chennai 7
Erbil 7
Franca 7
Goiânia 7
Kuala Lumpur 7
Moscow 7
Natal 7
Ninh Bình 7
Palermo 7
Panama City 7
Quảng Ngãi 7
Totale 4.755
Salva come PNG Salva come JPEG
Nome #
A State-of-the-Art Review of Ophthalmological Indications for a Cesarean Section: Is There a Patient for Whom a Cesarean Section Is Really Indicated? 121
The Accuracy of Third-Trimester Ultrasound in Predicting Large for Gestational Age or Macrosomic Fetuses in Diabetic and Non-Diabetic Pregnant Women: A Systematic Review and Meta-Analysis 98
A NEW ULTRASOUND CRITERIUM FOR THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME: PREDICTIVITY OF THE STROMA/AREA RATIO 94
Assessment of insulin resistance in lean women with polycystic ovary syndrome 92
A WHO 2021-based comprehensive scheme outlining sperm parameters’ associations with IVF outcomes in PGT-A cycles 89
AGEs-related dysfunctions in PCOS: evidence from animal and clinical research 85
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: A clinical, endocrinological, metabolic pilot study 85
A first stage placental site trophoblastic tumor: a case report and review of literature 82
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome 82
COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine 81
Alterazioni funzionali: patogenesi, diagnosi e terapia delle cause ovariche 80
Position paper on prevention of surgical site infections in obstetric and gynecological surgery 80
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome 78
Value of PGT-A when only one or two blastocysts are obtained: propensity-score matching and cost-effectiveness study 78
Acute insulin response to intravenous glucagon in polycystic ovary syndrome 76
A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome 76
Alterazioni della secrezione di GH nella sindrome dell'ovaio policistico: un nuovo fattore fisiopatologico 75
Clinical efficacy andmetabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study 75
Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin 74
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities 71
Endocrinology: Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome 71
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 71
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study 70
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: A pilot prospective study 70
Synchronous ovarian and uterine tumours: a case report of an unusual association 68
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 68
Progesterone: The Key Factor of the Beginning of Life 68
Asymptomatic postmenopausal endometrial thickening: a comparison between transvaginal ultrasound and hysteroscopy in the diagnosis of intracavitary uterine pathologies 68
Botulinum toxin in incontinent women with neurogenic bladder after failure with anticholinergic therapy, long-term results: a pilot study 68
Clinical, obstetric and perinatal outcomes after vitrified-warmed euploid blastocyst transfer are independent of cryo-storage duration 67
Alterazioni funzionali: patogenesi, diagnosi e terapia delle cause ovariche 67
Factors associated with chronic pelvic pain in women with endometriosis: A national study on clinical and sociodemographic characteristics, lifestyles, quality of life, and perceptions of quality of care, during the COVID-19 pandemic 67
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol with drospirenone in normal weight women with polycystic ovary syndrome 65
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome: Dexamethasone and GnRH-agonist administration 64
Differences in AMH levels in the four polycystic ovary syndrome phenotypes based on Rotterdam criteria 64
Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome 64
EFFECT OF THE INSULIN-SENSITIZING DRUG METFORMIN ON THE GROWTH HORMONE RESPONSE TP GROWTH HORMONE RELEASING HORMONE IN OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: RELATIONSHIP WITH FOOD INGESTION 64
Sex ratio at birth: causes of variation and narrative review of literature 63
INSULIN RESISTANCE AND WOMEN'S HEALTH 63
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles 63
Differentiation of spermatogenic cells during in-vitro culture of testicular biopsy samples from patients with obstructive azoospermia: Effect of recombinant follicle stimulating hormone 62
Human spermatogenesis in vitro: Respective effects of follicle- stimulating hormone and testosterone on meiosis, spermiogenesis, and sertoli cell apoptosis 62
DETRIMENTAL EFFECT OF AGE ON THE OVARIAN RESPONSE TO GONADOTROPIN AND ON PREGNANCY RATE IN POLYCYSTIC OVARIAN SYNDROME WOMEN 61
ADOLESCENTE CON ENDOMETRIOSI E PROSPETTIVE RIPRODUTTIVE. 61
INSULIN SECRETION IN POLYCYSTIC OVARY DISEASE (PCOD): A MULTIFACTORIAL PROBLEM 61
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome 60
ADOLESCENTE CON ENDOMETRIOSI E PROSPETTIVE RIPRODUTTIVE 59
Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: Effect of naloxone 59
Alterazioni della secrezione di GH nella sindrome dell'ovaio policistico: un nuovo fattore fisiopatologico 59
EFFECT OF PIOGLITAZONE TREATMENT ON THE ADRENAL ANDROGEN REPONSE TO CORTICOTROPHIN IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME 58
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS RESPONSE TO NALAXONE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME 58
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome 57
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL-AXIS RESPONSE TO NALOXONE IN PATIENTS WITH POLYCYSTIC SYNDROME 57
VAGINAL MESH REPAIR SYSTEMS FOR PELVIC ORGAN PROLAPSE: ANATOMICAL STUDY COMPARING OUTSIDE-IN VS INSIDE-OUT-TECHNIQUES 57
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes 56
L'INDUZIONE DELL'OVULAZIONE CON FSH PURIFICATO IN PAZIENTI AFFETTE DA SINDROME DELL'OVAIO POLICISTICO: POSSIBILI VANTAGGI DELLA TERAPIA A BASSE DOSI 56
RECOMBINANT versus URINARY FOLLICLE STIMULATING HORMONE (FSH) IN THE LOW-DOSE REGIMEN IN ANOVULATORY PATIENTS WITH POLICYSTYC OVARY SYNDROME (PCOS): A SAFER AND MORE EFFECTIVE TREATMENT 56
Conservative management of preterm premature rupture of membranes < 30 weeks of gestational age: Effectiveness of clinical guidelines implementation strategies 56
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: Relationship with insulin secretion 55
ENDOSCOPIC SURGERY IN OVARIAN ENDOMETRIOSIS: HISTOPATOLOGIC OBSERVATIONS ON THE LOSS OF FOLLICULAR TISSUE DURING TREATMENT 55
IS THERE A ROLE FOR ISOLAVONES IN THE THERAPEUTIC APPROCH TO POLYCYSTIC OVARY SYNDROME? RESULTS FROM A PILOT STUDY 55
Sonographic features of pelvic tuberculosis mimicking ovarian-tubal-peritoneal carcinoma 55
Vaginal mesh exposure after laparoscopic sacrocervicopexy performed with permanent or absorbable sutures 55
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 55
Metformin Effects tin Ovarian Ultrasound Appearance and Steroidogenic Function in Normal Weight, Normoinsulinemic Women with Polycystic Ovary Syndrome: A Randomized, Double Blind, Placebo-Controlled Clinical Trial 54
ALTERATION OF GHRELIN-NEUROPEPTIDE Y NETWORK IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME: ROLE OF HYPERINSULINISM 54
GH RESPONSE TO FOOD INTAKE IN OBESE pcos WOMEN: EFFECT OF METFORMIN 54
Perinatal mental illness and autoimmune diseases: a qualitative sistematic review 53
The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study 53
The Italian guidelines on non-invasive and invasive prenatal diagnosis: Executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology (SIGO) 53
Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome 53
Investigating Unhealthy Behaviors Associated with SF-36 Domains in Women with Endometriosis—Findings from a Web-Based Survey Data Set 53
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 53
METFORMIN TREATMENT DOSE NOT AFFECT TOTAL LEPTIN LEVELS AND FREE LEPTIN INDEX IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME 52
PIOGLITAZONE ADMINISTRATION IN HYPERINSULINEMIC WOMEN WITH PCOS DECREASES THE ADRENAL ANDROGEN RESPONSE TO CORTICOTROPHIN-RELEASING FACTOR 52
TOPICAL HAEMOSTATICS AND SEALANTS IN GYNAECOLOGICAL AND OBSTETRIC 3 SURGERY: STATE OF THE ART 52
Nerve-Sparing Laparoscopic Colposacropexy Using a Percutaneous Surgical System: A Case Report 52
Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome 51
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations. 51
How should the best human embryo in vitro be? Current and future challenges for embryo selection 51
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. 51
Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome 50
Using a 16-French Resectoscope as an Alternative Device in the Treatment of Uterine Lesions: A Randomized Controlled Trial 50
CONTRACCEZIONE ORMONALE E SINDROME DELL'OVAIO POLICISTICO 50
The Impact of Metal Nanoparticles on Female Reproductive System: Risks and Opportunities 50
Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib 50
OPIOIDS AND GROWTH HORMONE IN POLYCYSTIC OVARY SYNDROME. EFFECT OF FEEDING. 49
ROLE OF GnRH ANALOG PITUITARY DESENSITIZATION IN INDUCTION OF OVULATION IN POLYCYSTIC OVARIAN SYNDROME 49
Low AMH levels as a marker of reduced ovarian reserve in young women affected by Down syndrome 49
DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer 49
Posterior mesh fixation versus non-fixation in sacrocolpopexy: A randomized clinical trial 49
Ethinylestradio-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: Evaluation of the metabolic impact 48
Metaphase‑II oocyte competence is unlinked to the gonadotrophins used for ovarian stimulation: a matched case–control study in women of advanced maternal age 48
Conservative Management and Ultrasound Follow-Up of Parasitic Myoma: Our Experience and Literature Review 48
Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study 48
How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation 47
Longitudinal metabolic observation of metformin effects during pregnancy in women with polycystiv ovary syndrome 47
Endocrinology: Effect of opioid blockade on insulin metabolism in polycystic ovarian disease 47
The use of different size-hysteroscope in office hysteroscopy: our experience 47
Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: A case report 47
Totale 6.204
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.133
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 1 0 0 0 0 0
2023/20243 0 0 0 0 0 1 0 0 1 0 0 1
2024/20251.724 0 2 1 0 215 197 103 73 302 113 140 578
2025/20267.412 1.034 379 303 770 1.347 508 791 340 417 543 473 507
Totale 9.140